Pep-Back
Natural health product licensed in Canada
- Licence holder
- Kobayashi Healthcare International, Inc.
- NPN or DIN-HM
- 02238754
- Status
- Inactive licence
- Licence date
- 14 October 2009
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Caféine | 100 mg | Not calculated |
Non-medicinal ingredients
Bleu brillant, sel de sodium FCF, Lactose, gomme acacia, Carbonate de calcium, Acide stéarique, Carmin d'indigo, Quinoline Yellow WS, Polyoxyethylene (20) Sorbitan Monooleate, Poly(éthylène glycol), Cellulose, microcristalline, Hypromellose, Croscarmellose de sodium, Dioxyde de titane, Silicate de magnésium, Ethyl Vanillin, Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 3 hours ; maximum: 4 hours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps temporarily to promote alertness and wakefulness, and to enhance cognitive performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 02238754
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.